ArticleMolecular oncology2020

In vivo anti-V-ATPase antibody treatment delays ovarian tumor growth by increasing antitumor immune responses.

Arpita Kulshrestha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.